Head-to-head · Value Score
EdgeRx vs Eden
Two GLP-1 deals, scored on the same six factors. EdgeRx lands a Value Score of 82, Eden a 81. Here's who gives you the honest lower price — and where each one bites back.
EdgeRx
#50 · Grade B+ · Good Value
Est. first month
$229/mo
Save ~83% vs brand-nameEden
#60 · Grade B · Good Value
Est. first month
$239/mo
Save ~82% vs brand-nameFDA warning letter. The FDA issued Eden Health International Inc. dba Eden a warning letter in June 2026. Check it on the FDA database.
Get this deal Full Eden review →The verdict
EdgeRx takes it on Value Score, 82 to 81 — an est. $229/mo first month, with no teaser step-up baked in. Eden isn't out of it: Shoppers who'll trade a lower price for maximum disclosure and rock-solid nationwide access.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | EdgeRx | Eden |
|---|---|---|
| Value Score | 82 (B+) | 81 (B) |
| Est. first month | $229/mo | $239/mo |
| Save vs brand-name | ~83% | ~82% |
| Semaglutide | $229/mo injectable | $239/mo |
| Tirzepatide | $299/mo injectable | $349/mo |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | 46 states (excludes Arkansas, Indiana, Minnesota, South Carolina) | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
EdgeRx
A men's-only protocol shop with flat, disclosed GLP-1 pricing, a named Chief Medical Advisor, and a named 503A compounding pharmacy — rare transparency for this tier of the ranking.
Why it's a deal
- Both molecules disclosed up front — semaglutide $229/mo, tirzepatide $299/mo, both once-weekly injectable with free shipping and no separate physician fee
- Named compounding pharmacy — Strive Pharmacy, 503A, operating since 2018 — most peers name none
- Named Chief Medical Advisor, Dr. John Starke, MD (ABEM board-certified)
- LegitScript certified
The fine print
- Men-only — not built for, or marketed to, women or other readers
- The named Chief Medical Advisor does not personally prescribe; the actual prescribing pool is unnamed licensed physicians
- Third-party lab testing is claimed but no specific lab is named
- Excludes Arkansas, Indiana, Minnesota, and South Carolina
Eden
The priciest of the top programs we track, but the most transparent — you pay up, never get baited.
Why it's a deal
- Highest transparency — clear supply-chain and clinician disclosure
- Available in all 50 states
- Both molecules offered, no teaser tier
The fine print
- Most expensive on semaglutide among the top programs ($239/mo)
- Compounded only — no brand-name access
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores EdgeRx is ranked on the EdgeRx alternatives ranking, and the same list for the other side is on alternatives to Eden.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.